News and Announcements
China Roadshow announcement from Wholesale Investor
- Published August 16, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- For Founders and CEOs who are looking to discover their potential in the Chinese market, this is a unique opportunity.
- Across 4 cities, you will showcase to over 800+ Chinese Ultra High Net Worth Investors, Family Offices, Private Equity Firms and Venture Capitalists.
- If you are interested in joining us or learning more, please click here.
This November, Wholesale Investor is collaborating with Export Growth China, the New South Wales Business Chamber, China Council for Promotion of International Trade (CCPIT) and BMY Group to take 12 Australasian companies on a roadshow spanning across 4 Chinese cities – Shenzhen, Xiamen, Hangzhou and Shanghai.
With an ever-increasing Asian investor focus on Australasian emerging technology companies, we at Wholesale Investor would like to invite you or your investee company to join us on our China Investment Roadshow. For Founders and CEO’s who are looking to discover their potential in the Chinese market, this is a unique opportunity. Across 4 cities, you will showcase to over 800+ Chinese Ultra High Net Worth Investors, Family Offices, Private Equity Firms and Venture Capitalists.
We appreciate the ambition to expand overseas and attract commercial and investment opportunities in new markets. We highly encourage you to join us. If you are interested in joining us or learning more, please click here.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
